Zomebazam

This classification denotes an anxiolytic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G563Y6G60K. European Medicines Agency schedules Zomebazam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00184MIG. Zomebazam generally arises in the molecular formula C15H16N4O2. The term ZOMEBAZAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) ZOMEBAZAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zomebazam under HS 29337900 and SITC 51561. As of Q4 2014, ZOMEBAZAM remains the US FDA Preferred Term for this commodity. Zomebazam bears US NLM identifiers UMLS ID C1883611 and NCI Concept Code C66708. SMILES: O=C1N(C2C(N(C(=O)C1)C)N(NC2C)C)C1CCCCC1.